Comparative Pharmacology
Head-to-head clinical analysis: GEOCILLIN versus GEOPEN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: GEOCILLIN versus GEOPEN.
GEOCILLIN vs GEOPEN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Geocillin (carbenicillin indanyl sodium) is a penicillin antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to cell lysis and death. It exhibits bactericidal activity against susceptible gram-negative and gram-positive bacteria.
Carbenicillin is a bactericidal penicillin antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to cell lysis and death. It has activity against Gram-negative and some Gram-positive bacteria.
250-500 mg orally every 6 hours.
2 g intravenously every 6 hours for susceptible infections.
None Documented
None Documented
1.2 hours (normal renal function); prolonged to 7-10 hours in severe renal impairment (CrCl <10 mL/min).
Terminal half-life 4-6 hours in normal renal function; prolonged to 10-20 hours in moderate renal impairment (CrCl 10-50 mL/min) and up to 30-50 hours in severe impairment (CrCl <10 mL/min).
Primarily renal (70-80% unchanged via tubular secretion and glomerular filtration); minor biliary/fecal (<5%).
Renal: 80-90% unchanged via glomerular filtration and tubular secretion. Biliary/fecal: <2%.
Category C
Category C
Penicillin Antibiotic
Penicillin Antibiotic